Navigation Links
PharmaPoint: Non-Small Cell Lung Cancer - India Drug Forecast and Market Analysis to 2022
Date:9/12/2013

d 566.1 Overview 566.2 Improved Overall Survival and Less Toxicity 576.3 Treatments for Patients with Acquired TKI Resistance 586.4 Better Treatment Options for Squamous Patients 596.5 Preventing Relapse or Recurrence 596.6 More Efficacious Second-Line Therapies 606.7 Increased Availability of Mutation Testing 606.8 More Cost-Effective Therapies 616.9 Unmet Needs Gap Analysis 627 Pipeline Assessment 667.1 Overview 667.2 Promising Drugs in Clinical Development 667.2.1 nintedanib (BIBF1120) 707.2.2 Gilotrif (afatinib) 747.2.3 dacomitinib (PF-00299804) 807.2.4 LDK378 848 Market Outlook 908.1 India 908.1.1 Forecast 908.1.2 Key Events 948.1.3 Drivers and Barriers 949 Appendix 969.1 Bibliography 969.2 Abbreviations 1089.3 Methodology 1129.4 Forecasting Methodology 1129.4.1 Number of NSCLC Patients Currently Seeking Treatment 1129.4.2 Percent Drug-treated Patients 1139.4.3 Drugs Included in Each Therapeutic Class 1139.4.4 Launch and Patent Expiry Dates 1149.4.5 General Pricing Assumptions 1149.4.6 Individual Drug Assumptions 1179.4.7 Generic Erosion 1219.4.8 Pricing of Pipeline Agents 1229.5 Physicians and Specialists Included in This Study 1249.6 Survey of Prescribing Physicians 1269.7 About the Authors 1279.7.1 Authors 1279.7.2 Epidemiologists 1289.7.3 Global Head of Healthcare 1299.8 About GlobalData 1309.9 Disclaimer 130

1.1 List of Tables Table 1: Symptoms of Disease NSCLC 17

Table 2: Treatment Guidelines for NSCLC 19

Table 3: Stage Definitions for NSCLC 21

Table 4: Treatment Overview by Stage of Diagnosis for NSCLC 27

Table 5: Leading Treatments for NSCLC 33

Table 6: Product Profile – Alimta (pemetrexed disodium) 35

Table 7: Alimta SWOT Analysis, 2013 37

Table 8: Product Profile – Iressa (gefitinib) 39

Table 9: Iressa SWOT Analysis, 2013 42

Table 10: Product Profile – Tarceva (erlotinib hydrochloride) 44

Table 11: Tarceva SWOT Analysis, 2013 47'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
3. PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
4. PharmaPoint: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022
5. PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022
6. PharmaPoint: Dry Eye Syndrome - China Drug Forecast and Market Analysis to 2022
7. Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
8. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
9. Patient Advocate Foundation Receives Significant Support to Aid Non-Squamous Non-Small Cell Lung Cancer Patients through the Co-Pay Relief Program
10. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
11. NewLink Genetics Presents Positive Phase 2 Data on Novel Immunotherapy, Tergenpumatucel-L, in Non-Small Cell Lung Cancer at the ASCO 2013 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Inc. (Nasdaq: SMLR ), a company that provides ... groups, today reported financial results for the second quarter ... second quarter of 2015, Semler reported continued progress with ... quarter revenue growth of 8%, and quarter over quarter ... 18%," said Doug Murphy-Chutorian, M.D., chief executive officer of ...
(Date:7/31/2015)... July 31, 2015  Xencor, Inc. (NASDAQ: XNCR ... for the treatment of autoimmune diseases, asthma and allergic ... Yujiro S. Hata to its board of directors. ... and corporate development is a tremendous asset to our ... chief executive officer of Xencor. "Xencor faces a range ...
(Date:7/31/2015)... , July 31, 2015 ... solutions for video, data and cloud computing operators ... a leading pharma giant for Internet of Things ... IoT applications offered on subscription model. ... Pharma giant is striving for business innovations to ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... HORSHAM, Pa., Sept. 20, 2011 Verilogue, the ... upcoming presentations highlighting company initiatives, including CareCoach.com, the ... healthcare dialogue between patients, caregivers and their physicians. ... conferences in September: e-Patient Connections; ...
... Sept. 20, 2011 Reportlinker.com announces that a ... catalogue: Rheumatoid Arthritis Market Forecast ... The launch of novel oral drugs and reformulations ... across the seven major markets, rising from $12bn ...
Cached Medicine Technology:Verilogue to Present at Upcoming Health IT and Patient-Focused Conferences 2Rheumatoid Arthritis Market Forecast 2
(Date:7/31/2015)... ... July 31, 2015 , ... ... to release a newly redesigned website at Healthpointe.net. The new website will feature ... , The redesign serves to provide smoother interactions between patients and the ...
(Date:7/31/2015)... McLean, VA (PRWEB) , ... July 31, 2015 , ... ... solution at OSEHRA 2015. , What is HITaaS? Health IT as a Service (HITaaS) ... (IaaS) and software as a service (SaaS). , HITaaS manages all aspects ...
(Date:7/31/2015)... ... July 31, 2015 , ... EB Medicine, leading publisher ... Practice, is pleased to announce that it has partnered with AgileMD to release ... iPhones, iPads, and Android smartphones and tablets. , “The April 2015 launch ...
(Date:7/31/2015)... ... 31, 2015 , ... The Radiology Business Management Association’s 2015 ... Next for Health Care: A View From Capitol Hill” on Sunday, Sept. 27, 2015, ... Caucus, Rep. Burgess has a special understanding of the real world impact of health ...
(Date:7/31/2015)... ... 2015 , ... Super-Sod wants to participate in planning new home lawns from ... the perfect fit for such a goal. Houzz is a social media site that ... dynamic site that spreads home and home garden design ideas when members share their ...
Breaking Medicine News(10 mins):Health News:Healthpointe Announces Newly Redesigned Website 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 2Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 3Health News:ZH Healthcare Unveils Health IT as a Service (HITaaS) at OSEHRA 2015 4Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 2Health News:EB Medicine Launches Mobile Application for Pediatric Emergency Medicine 3Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 2Health News:Congressional Health Caucus Founder Rep. Michael Burgess, MD, to Speak at RBMA Fall Educational Conference 3Health News:Super-Sod Created a Landscape Profile on Houzz.com for Home Garden Design 2
... needed from the rich countries to achieve the universal goal ... ,Five times more money is needed to meet the ... of papers published online by the Lancet today. It coincides ... the Norwegian government. , ,According to Timothy Powell-Jackson ...
... extensively used to treat acne can cause depression. This ... ,Recently, the drug- Roaccutane, which effectively cures ... side-effects like suicidal behaviour. Though the packaging of the ... of such side-effects is not known.,It has not been ...
... had Shah Rukh Khan at the ceremony in Bangalore. Biocon's ... be priced at 40 percent of what similar drugs marketed ... of MAb developers worldwide. We want to be a key ... drug was undergoing regulatory processes for South Asian markets, but ...
... contend with now - a sharp rise in HIV/AIDS cases. ... insurgency-hit state, unofficial estimates peg the number at 25,000.// ... Grassroots Features. The northern state lies in a low prevalence ... (STD-infected) at 0.95 percent and among the low-risk groups at ...
... Claudia Mitchell, was a United States Marine who lost her arm in ... with a new prosthetic arm that is controlled by her own nerves. ... a steak which was the first that she had been able to ... ago. She said, “That was a very big thing for me.” ...
... site at the University of California, San Diego (UCSD) ... from around the world// to self-report adverse effects of ... ,“This line of research is important because ... cholesterol are familiar with the benefits of statins and ...
Cached Medicine News:Health News:Child death reduction needs five times more funds 2Health News:Acne drug may cause depression 2Health News:Kashmir Grapples with Growing AIDS 2Health News:Kashmir Grapples with Growing AIDS 3Health News:Bionic Women –No longer the Stuff of Science Fictio 2Health News:Patients Can Report Statins' Adverse Effects on New Web Site 2
... needed for quality, comprehensive portable and bedside ... allows you to see up to four ... touch screen allows easy navigation through menus ... temperature., ,Standard features include two channels ...
... all-in-one anesthesia monitor., ,The Cardiocap/5 ... for use in the operating room, ... PACU. The Cardiocap/5 offers full vital ... of oxygenation and circulation to advanced ...
... tool for Clinical Professionals and Researchers., ,S/5 ... easy and efficient way to collect data from ... to days at selectable time intervals. With S/5 ... from the monitor via an interface cable or ...
... for intermediate care., ,The S/5 FM is ... S/5 product line., ,The S/5 FM has ... to grow. The new Patient Side Module (PSM) ... up to 12-lead ECG, NIBP, motion-tolerant SpO 2 ...
Medicine Products: